Comparison of endoscopic variceal ligation and nadolol plus issorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients

Journal of the Chinese Medical Association

Volumn 69, Issue 10, 2006, Pages 453-460

  Wang, Huay Min ^a   Lo, Gin Ho ^a   Chen, Wen Chi ^a   Tsai, Wei Lun ^a   Chan, Hoi Hung ^a   Cheng, Lung Chih ^a   Hsu, Ping I ^a   Lai, Kwik Hung ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Banding ligation; Isosorbide 5 mononitrate; Nadolol; Variceal bleeding

Indexed keywords

ANALGESIC AGENT; ISOSORBIDE 5 NITRATE; NADOLOL;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPHAGIA; ENDOSCOPIC SURGERY; ESOPHAGUS ULCER; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SAFETY; PROPORTIONAL HAZARDS MODEL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RETROSTERNAL PAIN; RISK FACTOR; STOMACH VARICES; SURGICAL EQUIPMENT; SURGICAL MORTALITY; UPPER GASTROINTESTINAL BLEEDING; VEIN LIGATION; VEIN OCCLUSION;

EID: 33750846835     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70309-0     Document Type: Article

References (27)

1. Lake JR, Howdle PD. Gastrointestinal hemorrhage and portal hypertension. In: O'Grady JG, Lake JR, Howdle PD, eds. Comprehensive Hepatology. London: Mosby, 2000:1-13.
2. Pagliaro L, D'Amico G, Sorensen TI, Lebrec D, Burroughs AY, Morabito A, Tine F, et al. Prevention of first bleeding in cirrhosis: a meta-analysis of randomized trials of nonsurgical treatment. Ann Int Med 1992;117:59-70.
3. Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol 1999;31:451-6.
4. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal bleeding. Hepatology 2001;33:1003-4.
5. Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, Cheng JS, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastro-intest Endosc 2004;59:333-8.
6. Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P, Amodio P, et al. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000; 31:324-9.
7. Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P, Amodio P, et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Lancet 1996;348:1677-81.
8. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
9. Beppu K, Inokuchi Y, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-8.
10. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005;21:347-61.
11. Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997;112:473-82.
12. Abraczinskas DR, Ookubo R, Grace ND, Groszmarm RJ, Bosch J, Garcia-Tsao G, Richardson CR, et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology 2001;34:1096-102.
13. Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, Audano M. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 1987;7:648-53.
14. Lebrec D, Bernuau J, Rueff B, Benhamou JP. Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis. N Engl J Med 1982;307:560.
15. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120:726-48.
16. Garcia-Pagan JC, Feu F, Bosch J, Rodes J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. Ann Intern Med 1991;115:869-73.
17. Patti R, D'Amico G, Pasta L, Vizzini G, Traina M, Madonia S, Licata A. Isosorbide mononitrate (IMN) with nadolol compared to nadolol alone for prevention of recurrent bleeding in, cirrhosis: a double-blond placebo-controlled randomised trial. J Hepatol 1999;30(Suppl):81A.
18. Garcia-Pagan JC, Morillas R, Banares R, Albillos A, Villanueva C, Vila C, Genesca J, et al. Propranolol plus placebo vs. propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003;37:1260-6.
19. Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology 2000;31:1239-45.
20. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930-4.
21. Albillos A, Garda-Pagan JC, Iborra J, Bandi JC, Cacho G, Perez-Paramo M, Escorsell A, et al. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology 1998; 115:116-23.
22. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 1995;123:280-7.
23. Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, Wu KL, Lo KJ. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997;25:1346-50.
24. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340:988-93.
25. Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, Finlayson ND, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123:735-44.
26. Borroni G, Salerno F, Cazzaniga M, Bissoli F, Lorenzano E, Maggi A, Visentin S, et al. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. J Hepatol 2002;37:315-21.
27. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz S, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-55.